Serum Procalcitonic (PCT) Versus Serum C - Reactive Protein (CRP) for Severity of Organ Dysfunction in Sepsis
Keywords:
SIRS (Systemic Inflammatory Response Syndrome), SOFA (Sequential Organ Failure Assessment), Sepsis, Procalcitonin (PCT)Abstract
Background: Intensive care units (ICUs), despite advances in critical care nursing, have frequent issues with early diagnosis and adequate treatment. Recently discovered world-class procalcitonin (PCT), a revolutionary laboratory marker, has been shown to be useful in this regard. The objective is to Comparison of concentrations of serum procalcitonin (PCT) and c-reactive protein (CRP) with a comparable level of organ malfunction during sepsis and evaluation of the interaction between serum PCT and CRP concentrations with different organ malfunction occurrence in sepsis. Design: It is a Hospital-Based Prospective study. Participants and Setting: Fifty people were admitted to the intensive care unit of Gandhi Medical College. Subjects and Methods: The extent of sepsis-related organ impairment was evaluated with the sequential organ failure assessment (SOFA) on day 1. Patients were identified by category 1(0-6), category 2(7-12), group 3(13-18), and group 4(19-24) in 4 separate classes with varying organ impairment seriousness of sepsis. Serum PCT and CRP concentrations have been measured. Results: The majority of the patients belonged to the age groups of 60-69 years (30%) and 50-59 years (22%) Majority of the patients belonged to the Sofa group 1 around 42% followed by sofa group 2 with 38%, sofa group 3 with 16% and the least belonged to the sofa group 4 with 4%. The mean PCT and CRP concentration in those who survived was 14.73 ng/ml and 149.916mg/L respectively and in those who died were 45.76 ng/ml (p-value <0.001) and 183.584 mg/L (p-value 0.172) respectively. The linear correlation between PCT plasma concentrations and the four groups was significantly stronger than with CRP. Conclusion: In SOFA and serum PCT, The level of organ dysfunction and complications in sepsis patients is closely related to serum CRP levels.
Downloads
References
re Medicine Consensus Definition for sepsis and organ failure and guidelines for the innovative therapies in sepsis. Crit Care Med. 1992;20(6):864–874.
2. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The Natural History of the Systemic Inflammatory Response Syndrome (SIRS). JAMA. 1995;273(2):117– 123. Available from: https://dx.doi.org/10.1001/jama.1995. 03520260039030.
3. Bone RC, Fisher CJ, Clemmer TP. Sepsis syndrome: A valid clinical entity. Crit Care Med. 1989;17(5):389–393. 4. Vincent JL, Ferreira F, Moreno R. Scoring Systems for Assessing Organ Dysfunction and Survival. Crit Care Clin. 2000;16(2):353–366. Available from: https://dx.doi.org/10. 1016/s0749-0704(05)70114-7.
5. Oberhofer M, Bögel D, Meier-Hellmann A. Procalcitonin is higher in non- survivors during the clinical course of sepsis, severe sepsis and septic shock. Intensive Care Med. 1996;22:245–245.
6. Zeni F, Viallon A, Assicot M. Procalcitonin serum concentra tions and severity of sepsis. Clin Intense Care. 1994;5(2):89– 98.
7. Al-Nawas B, Krammer I, Shah PM. Procalcitonin in the diagnosis of severe infections. Eur J Med Res. 1996;1(7):331– 333.
8. Gramm HJ, Dollinger P, Beier W. Procalcitonin - einneuer Marker der inflammatorischenwirtsantwort. Longitudinalstudi enbeiPatientenmit sepsis und Peritonitis. ChirGastroenterol. 1995;11(2):51–54. Available from: https://doi.org/10.1159/ 000189907.
9. de Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations. Crit Care Med. 1997;25(4):607–613. Available from: https://dx.doi. org/10.1097/00003246-199704000-00009.
10. Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C- reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Critical Care. 2004;8(4):234–242.
